Angiogenesis inhibitors and radiotherapy of primary tumours

Bibliography

• FOLKMAN J: Tumor angiogenesis: therapeutic, implications. N Engl. I Med. (1971) 285:1182–1186.
   PubMed Web of Science ®Google Scholar
• ••The birth of modem angiogenesis.
   Google Scholar
• FANG J, SHING Y, WIEDERSCHAIN D et al.: Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc. Nati Acad. Sci. USA (2000) 97(5):3884–3889.
   PubMedGoogle Scholar
• FOLKMAN J: Tumor angiogenesis. In: Cancer Medicine. Holland JF, Frei E, Bast RC,, Kufe DW, Morton DL, Weichselbaum RR (eds), Williams and Wilkens, Baltimore (1996):181–204.
   Google Scholar
• O'REILLY MS, HOLMGREN L, SHING Y et al.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma. Cell (1994) 79:315–328.
   Google Scholar
• ••The tumour-derived inhibitor of angiogenesis,.
   Google Scholar
• O'REILLY MS, BOEHM T, SHING Y et al: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 88:277–285.
   PubMed Web of Science ®Google Scholar
• O'REILLY MS, PIRIE-SHEPHERD S, LANE WS, FOLKMAN J: Antiangiogenic activity, of the cleaved conformation of the serpin antithrombin. Science (1999) 285:1926–1928.
   PubMed Web of Science ®Google Scholar
• TEICHER B, SOTOMAYOR E, HUANGZ: Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res. (1992) 52:6702–6704.
   PubMed Web of Science ®Google Scholar
• BROWDER T, BUTTERFIELD CE, KRALING BM et al.: Antiangiogenic scheduling, of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. (2000) 60:1878–1886.
   PubMed Web of Science ®Google Scholar
• KLEMENT G, BARUCHEL S, RAK J et al.: Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces, sustained tumor regression without overt toxicity. Clin. Invest. (2000) 105(8):15–24.
   Google Scholar
• PARIS F, FUKS Z, KANG A, CAPODIECI P et al.: Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 293:293–297.
   PubMed Web of Science ®Google Scholar
• DENEKAMP J: Endothelial cell proliferation, as a novel approach to targeting tumour therapy. Br. J. Cancer (1982) 45:136–141.
   PubMed Web of Science ®Google Scholar
• ARAP W: Targeting the prostate for destruction through a vascular address. Proc. Natl. Acad. Sci. USA (2002) 990:1527–1531.
   Google Scholar
• FOLKMAN J: Tumor angiogenesis factor. Cancer Res. (1974) 34:2109–2113.
   PubMed Web of Science ®Google Scholar
• FOLKMAN J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. (1995) 1(1):27–31.
   PubMed Web of Science ®Google Scholar
• DONG Z, KUMAR R, YANG X, FIDLER II: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell (1997) 88:801–810.
   PubMed Web of Science ®Google Scholar
• O'REILLY MS, WIEDERSCHAIN D, STETLER-STEVENSON WG, FOLKMAN J, MOSES MA: Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. (1999) 274(41):29568–29571.
   PubMed Web of Science ®Google Scholar
• WEN W, MOSES MA, WIEDERSCHAIN D,, ARBISERJL, FOLKMAN J: The generation, of endostatin is mediated by elastase. Cancer Res. (1999) 59:6052–6056.
   PubMed Web of Science ®Google Scholar
• FELBOR U, DREIER L, BRYANT RA, PLOEGH HL, OLSEN BR, MOTHESW: Secreted cathepsin L generates endostatin from collagen XVIII. EMBO (2000) 19(01187–1194.
   PubMed Web of Science ®Google Scholar
• HALL E: Radiobiology for the radiologist (5th edn), Lippincott Williams and Wilkins, Baltimore (2000):588.
   Google Scholar
• TEICHER A, DUPIS N, KUSOMOTO T et al.: Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy. Radiat. Oncol. Investig. (1995) 2:269–276.
   Google Scholar
• ••Breaking the hypoxic dogma.
   Google Scholar
• GRIFFIN RJ, WILLIAMS BW, WILD R, CHERRINGTON JM, PARK H, SONG CW Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation responses. Cancer Res. (2002) 62:1702–1706.
   PubMed Web of Science ®Google Scholar
• LEE CG, HEIJN M, DI TOMASO E et al:Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res. (2000) 60:5565–5570.
   PubMed Web of Science ®Google Scholar
• TEICHER BA, HOLDEN SA, ARA G: Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int. J. Cancer (1994) 57:920–925.
   PubMed Web of Science ®Google Scholar
• SOLESVIK O, ROFSTAD E, BRUSTAD T: Vascular changes in a human malignant melanoma xenograft following single-dose irradiation. Radiat. Res. (1984) 98:115–128.
   PubMed Web of Science ®Google Scholar
• MAUCERI HJ, HANNA NN, BECKETT MA et al.: Combined effects of angiostatin and ionizing radiation in antitumor therapy. Nature (1998) 394:287–291.
   PubMed Web of Science ®Google Scholar
• GORSKI DH, MAUCERI HJ, SALLOUM RM et al.: Potentiation of the antitumor effect of ionizing radiation by brief concomitant, exposures to angiostatin. Cancer Res. (1998) 58:5686–5689.
   PubMed Web of Science ®Google Scholar
• HANNA NN, SEETHARAM S, MAUCERI, Hi et al.: Antitumor interaction of, short-course endostatin and ionizingradiation. Cancer (2000) 6:287–293.
   Web of Science ®Google Scholar
• DENEKAMP J: Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev (1990) 9:267–282.
   PubMed Web of Science ®Google Scholar
• TATUM J, HOFFMAN J: Role of imaging in clinical trials of antiangiogenesis therapy in oncology. Acad. Radial. (2000) 7(10):798–799.
   PubMed Web of Science ®Google Scholar
• CHENG WE LEE CN, CHU JS: Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer (1999) 85(3):651–657.
   PubMed Web of Science ®Google Scholar
• MILES K: Tumor angiogenesis and its relation to contrast enhancement on computed tomography: a review. Ear: Radial. (1999) 30:198–205.
   PubMed Web of Science ®Google Scholar
• SIPKINS DA, CHERESH DA, KAZEMI MR, NEVIN LM, BEDNARSKI MD, LI KC: Detection of tumor angiogenesis in vivo by alphaV-beta3 targeted magnetic resonance imaging. Nat. Med. (1998) 4(5):623–626.
   PubMed Web of Science ®Google Scholar